Biologics Distributor for Montgomery, AL Medspas and Dermatology

Vendor review for medspas under physician supervision

Medspas that operate under physician supervision, along with dermatology and aesthetic surgery practices, generally route new biologics vendors through the supervising physician or medical director before any product is approved for the practice's purchasing list. That review tends to focus on the supplier's documentation: registration status, sample certificates of analysis, donor eligibility summaries, and a written account of how tissue and exosome material is recovered, tested, and released.

Because medspas often operate across multiple locations under one medical director, the review also commonly asks how lot numbers are recorded at the patient record level.

NPI-verified accounts

Precision Biologics ties every account to a verified NPI number for the ordering provider or medical director of record. This matches how most dermatology and aesthetic practices already manage their supervising-physician requirements, and it gives the practice a clear line of accountability for any purchase.

Cold chain and receiving in the Southeast

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers designed to maintain a -80 degree C chain of custody, and lyophilized exosome formats are shelf-stable and handled per the storage instructions in the product insert.

Medspas and dermatology offices receiving shipments should designate a staff member to accept and store product immediately on arrival, since front-desk schedules at aesthetic practices can make same-day receiving less predictable than at a hospital-based clinic.

Confirming scope of practice before purchase

Medical spa ownership and supervision structures vary, so Precision Biologics recommends confirming scope-of-practice requirements for the supervising physician with the Alabama Board of Medical Examiners and the practice's own legal counsel before adding any regenerative biologic to the service menu.

Precision Biologics supplies documented products and supporting records only; it does not advise on clinical use, dosing, or procedures. A peer-to-peer call with a physician on staff is available to walk through documentation.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.